RxDoctor Payments Data

Andrew Moon, MD

Orthopaedic Surgery of the Spine · Hopedale, MANPI 1871159848

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.1%), food and beverage and education — rather than concentrated in one kind of arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.6%. 2025 is the largest year on record at $9,050, more than ten times the $412 reported in 2020. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in MA, where the typical reported total is $21,142.

$13,975in general payments, 2019–2025

Across 90 payments — averaging $155.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$3K
  • Spineart USA Inc$3K
  • Medical Device Business Services, Inc.$2K
  • Alphatec Spine, Inc$1K
  • Synthes GmbH$1K
  • Arthrex$955
  • plus $3K from 13 others

What the payments were for

  • Travel & lodging$7,55854%
  • Food & beverage$5,22737%
  • Education$1,1909%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,975 in reported general payments places this provider in the 40th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$21,159
Medicare patients
50
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron26$181
Methocarbamol11$79
Oxycodone Hcl17$66

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Hopedale

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →